Molecular characterization of composite mantle cell and follicular lymphoma
✍ Scribed by Alberto Zamò; Roberta Zanotti; Maurizio Lestani; German Ott; Tiemo Katzenberger; Aldo Scarpa; Giovanni Pizzolo; Fabio Menestrina; Marco Chilosi
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 265 KB
- Volume
- 448
- Category
- Article
- ISSN
- 1432-2307
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Advanced‐stage follicular lymphoma (FL) and mantle cell lymphoma (MCL) cannot be cured using conventional chemotherapy. Fludarabine, the most widely used purine analog, exhibits a particularly high level of activity against small lymphocytic lymphoma and chronic lymphocytic leukemia (CL
Mantle cell lymphoma (MCL) accounts for 5-10% of non-Hodgkin's lymphomas and it bears the worst prognosis among B cell lymphomas. Even more than in the other lymphomas, new insights in MCL biology are needed. In this review we will discuss the most recent published data. Immunoglobulin sequencing da